Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (7)
- Computational Biology (2)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (7)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (12)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Topics
- (-) Biomedical (62)
- (-) Microelectronics (4)
- 3-D Printing/Advanced Manufacturing (128)
- Advanced Reactors (35)
- Artificial Intelligence (102)
- Big Data (62)
- Bioenergy (92)
- Biology (102)
- Biotechnology (24)
- Buildings (67)
- Chemical Sciences (74)
- Clean Water (31)
- Climate Change (106)
- Composites (30)
- Computer Science (199)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (85)
- Education (5)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (201)
- Exascale Computing (44)
- Fossil Energy (6)
- Frontier (46)
- Fusion (59)
- Grid (67)
- High-Performance Computing (94)
- Hydropower (11)
- Irradiation (3)
- Isotopes (57)
- ITER (7)
- Machine Learning (51)
- Materials (150)
- Materials Science (149)
- Mathematics (10)
- Mercury (12)
- Microscopy (51)
- Molten Salt (9)
- Nanotechnology (60)
- National Security (73)
- Net Zero (14)
- Neutron Science (140)
- Nuclear Energy (111)
- Partnerships (51)
- Physics (64)
- Polymers (33)
- Quantum Computing (39)
- Quantum Science (73)
- Renewable Energy (2)
- Security (26)
- Simulation (53)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (61)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (99)
Media Contacts
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.